Takeda

Takeda to cut IT, marketing and sales jobs after Shire merger
Takeda to cut IT, marketing and sales jobs after Shire merger
Pharmaforum
Takeda
Shire
M&A
layoffs
Flag link:
Takeda Finally Inks a Deal to Buy Shire in One of the Biggest Pharma Takeovers Ever
Takeda Finally Inks a Deal to Buy Shire in One of the Biggest Pharma Takeovers Ever
Fortune
Takeda
Shire
M&A
Flag link:
Takeda Nears Deal to Buy Shire in Its Biggest Purchase
Takeda Nears Deal to Buy Shire in Its Biggest Purchase
Bloomberg
Takeda
Shire
M&A
Flag link:
4 Huge Pharma Deals in 4 Months Is Just the Beginning
4 Huge Pharma Deals in 4 Months Is Just the Beginning
Motley Fool
M&A
Takeda
Shire
Novartis
AveXis
Sanofi
Bioverativ
Celgene
Juno Therapeutics
Flag link:
Hey, Takeda shareholders: Shire's Q1 may ease some buyout worries, analysts say
Hey, Takeda shareholders: Shire's Q1 may ease some buyout worries, analysts say
Fierce Pharma
Takeda
Shire
M&A
earnings
Flag link:
Takeda reaches preliminary deal to buy Shire for close to $65B
Takeda reaches preliminary deal to buy Shire for close to $65B
Endpoints
Takeda
Shire
M&A
Flag link:
Shire Shares Gain After Deal With Takeda Nears Completion
Shire Shares Gain After Deal With Takeda Nears Completion
Bloomberg
Shire
Takeda
M&A
Flag link:
After some Thursday drama, Shire weighs Takeda's cash-sweetened $61.5B offer
After some Thursday drama, Shire weighs Takeda's cash-sweetened $61.5B offer
Fierce Pharma
Shire
Takeda
M&A
Flag link:
Pressing for direct negotiations, Takeda adds cash to a meatier $63B bid to buy Shire
Pressing for direct negotiations, Takeda adds cash to a meatier $63B bid to buy Shire
Endpoints
Shire
Takeda
M&A
Flag link:
Allergan will not bid for Shire: Sources
Allergan will not bid for Shire: Sources
CNBC
Allergan
Shire
M&A
Takeda
Flag link:
A bidding war is brewing over $50 billion drugmaker Shire
A bidding war is brewing over $50 billion drugmaker Shire
Business Insider
Shire
Takeda
Allergan
M&A
Flag link:
Takeda makes $61 billion bid for drugmaker Shire: sources
Takeda makes $61 billion bid for drugmaker Shire: sources
Reuters
Takeda
Shire
M&A
Flag link:
Shire's oncology exit weighs on potential Takeda bid
Shire's oncology exit weighs on potential Takeda bid
Biopharma Dive
Shire
oncology
Takeda
M&A
Servier
Flag link:
Servier buys Shire’s oncology unit for $2.4B in the run-up to Takeda’s final buyout offer — if it makes one
Servier buys Shire’s oncology unit for $2.4B in the run-up to Takeda’s final buyout offer — if it makes one
Endpoints
Servier
Shire
Takeda
M&A
oncology
Flag link:
[video]Will Shire Be Bought Out?
[video]Will Shire Be Bought Out?
Motley Fool
Shire
M&A
Takeda
Flag link:
Hopes rise for Shire sale as Takeda CEO discusses case for deal
Hopes rise for Shire sale as Takeda CEO discusses case for deal
NASDAQ.com
Shire
Takeda
Pharma CEOs
M&A
Christophe Weber
Flag link:
Will flush-with-cash Big Pharma beat Takeda to a Shire deal?
Will flush-with-cash Big Pharma beat Takeda to a Shire deal?
Fierce Pharma
Takeda
Shire
M&A
Big Pharma
Flag link:
Does a $50B-plus Shire buyout even make sense for Takeda? Maybe not
Does a $50B-plus Shire buyout even make sense for Takeda? Maybe not
Endpoints
Shire
Takeda
M&A
Flag link:
Drugmaker Shire soars as Japan's Takeda considers bid
Drugmaker Shire soars as Japan's Takeda considers bid
CNBC
Shire
Takeda
M&A
Flag link:
Takeda-partnered Finch Therapeutics grabs $36M and looks to leapfrog the pack in microbiome R&D
Takeda-partnered Finch Therapeutics grabs $36M and looks to leapfrog the pack in microbiome R&D
Endpoints
Takeda
Finch Therapeutics
microbiome
R&D
Flag link:

Pages